Medications with narrow therapeutic windows (like warfarin, levothyroxine, or certain diabetes medications) may need dose adjustments when combined with semaglutide
GLP-1 medications like semaglutide are not recommended for individuals with a history of: Medullary thyroid carcinoma (or a family history of it) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis or gallbladder disease Severe gastrointestinal disorders FuturHealth clinicians screen all patients for these risk factors during the onboarding process
For example, IGF-1 treatment has been found to increase bone mineral density and enhance the structural properties of the healed bone, making it stronger and less prone to re-injury (Locatelli & Bianchi., 2014)
When treated for 16 weeks, KD-fed rats showed increased heart rates and impaired cardiac function
Beginning in late 2025, coverage will tighten to focus only on those with higher BMIs or qualifying medical conditions, leaving many individuals unsure whether their treatment will continue
References For Further Reading (1) A M Reznichenko, V P Fesenko, D V Shestopalov, and P A Tatarchuk (2001) Changes in cell immunity indexes under the influence of thymalin, thyroxine and fibronectin in patients with hyperplastic diseases of thyroid gland before and after the surgery Klin Khir, 2001 Dec: (12): Pages 31-3